PubMed

High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy.

Fan X, Mao Q, Zhou D, Lu Y, Xing J, Xu Y, Ray SC, Di Bisceglie AM.

Hepatology. 2009 Dec;50(6):1765-1772.PMID: 19937690 [PubMed - as supplied by publisher]

Des-gamma-Carboxy Prothrombin and alpha-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma.

Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, Morgan TR, Kim HY, Lee WM, Bonkovsky HL, Dienstag JL; HALT-C Trial Group.

Gastroenterology. 2009 Oct 20. [Epub ahead of print]PMID: 19852963 [PubMed - as supplied by publisher]Related articles

Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C.

Ghany MG, Lok AS, Everhart JE, Everson GT, Lee WM, Curto TM, Wright EC, Stoddard AM, Sterling RK, Di Bisceglie AM, Bonkovsky HL, Morishima C, Morgan TR, Dienstag JL; HALT-C Trial Group.

Gastroenterology. 2009 Sep 18. [Epub ahead of print]PMID: 19766643 [PubMed - as supplied by publisher]Related articles

Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the Halt-C Trial.

Shiffman ML, Morishima C, Dienstag JL, Lindsay KL, Hoefs JC, Lee WM, Wright EC, Naishadham D, Everson GT, Lok AS, Di Bisceglie AM, Bonkovsky HL, Ghany MG; HALT-C Trial Group.

Gastroenterology. 2009 Sep 10. [Epub ahead of print]PMID: 19747918 [PubMed - as supplied by publisher]Related articles

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC, Dienstag JL, Morishima C, Abnet CC, Sinha R; HALT-C Trial Group.

Hepatology. 2009 Nov;50(5):1360-9.PMID: 19676128 [PubMed - in process]Related articles

Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma.

Wang M, Long RE, Comunale MA, Junaidi O, Marrero J, Di Bisceglie AM, Block TM, Mehta AS.

Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1914-21. Epub 2009 May 19.PMID: 19454616 [PubMed - indexed for MEDLINE]Related articles

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, Di Bisceglie AM, Ghany MG, Gretch DR, Chanock SJ, Chung RT, O'Brien TR; HALT-C Trial Group.

Hepatology. 2009 Jun;49(6):1847-58.PMID: 19434718 [PubMed - indexed for MEDLINE]Related articles

Clinical decisions. Management of incidental hepatitis C virus infection.

Afdhal NH, Lok AS, Di Bisceglie AM.

N Engl J Med. 2009 Apr 30;360(18):1902-6. No abstract available. PMID: 19403909 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B and hepatocellular carcinoma.

Di Bisceglie AM.

Hepatology. 2009 May;49(5 Suppl):S56-60.PMID: 19399807 [PubMed - indexed for MEDLINE]Related articles

Lack of association between genotypes and subtypes of HCV and occurrence of hepatocellular carcinoma in Egypt.

Ryu SH, Fan X, Xu Y, Elbaz T, Zekri AR, Abdelaziz AO, Di Bisceglie AM.

J Med Virol. 2009 May;81(5):844-7.PMID: 19319951 [PubMed - indexed for MEDLINE]Related articles

Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.

Lok AS, Everhart JE, Chung RT, Kim HY, Everson GT, Hoefs JC, Greenson JK, Sterling RK, Lindsay KL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Ghany MG, Morishima C; HALT-C Trial Group.

Hepatology. 2009 Jun;49(6):1828-37.PMID: 19291787 [PubMed - indexed for MEDLINE]Related articles

Evidence for action of ribavirin through the hepatitis C virus RNA polymerase.

Cannon NA, Donlin MJ, Mayes LM, Lyra AC, Di Bisceglie AM, Tavis JE.

J Viral Hepat. 2009 Aug;16(8):595-604. Epub 2009 Feb 23.PMID: 19243495 [PubMed - indexed for MEDLINE]Related articles

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients.

George SL, Bacon BR, Brunt EM, Mihindukulasuriya KL, Hoffmann J, Di Bisceglie AM.

Hepatology. 2009 Mar;49(3):729-38.PMID: 19072828 [PubMed - indexed for MEDLINE]Related articles

Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL; HALT-C Trial Investigators.

N Engl J Med. 2008 Dec 4;359(23):2429-41.PMID: 19052125 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD; HALT-C Trial Group.

Gastroenterology. 2009 Jan;136(1):138-48. Epub 2008 Sep 18.PMID: 18848939 [PubMed - indexed for MEDLINE]Related articles

Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirin.

Fried MW, Jensen DM, Rodriguez-Torres M, Nyberg LM, Di Bisceglie AM, Morgan TR, Pockros PJ, Lin A, Cupelli L, Duff F, Wang K, Nelson DR.

Hepatology. 2008 Oct;48(4):1033-43.PMID: 18697207 [PubMed - indexed for MEDLINE]Related articles

Comparative analysis of nearly full-length hepatitis C virus quasispecies from patients experiencing viral breakthrough during antiviral therapy: clustered mutations in three functional genes, E2, NS2, and NS5a.

Xu Z, Fan X, Xu Y, Di Bisceglie AM.

J Virol. 2008 Oct;82(19):9417-24. Epub 2008 Jul 30.PMID: 18667493 [PubMed - indexed for MEDLINE]Related articlesFree article

Design and endpoints of clinical trials in hepatocellular carcinoma.

Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of Experts in HCC-Design Clinical Trials.

J Natl Cancer Inst. 2008 May 21;100(10):698-711. Epub 2008 May 13. Review.PMID: 18477802 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.

Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC; Public Policy Committee of the American Association for the Study of Liver Disease.

Hepatology. 2008 Apr;47(4):1363-70. No abstract available. PMID: 18366115 [PubMed - indexed for MEDLINE]Related articles

Diagnosis of hepatocellular carcinoma.

Bialecki ES, Di Bisceglie AM.

HPB (Oxford). 2005;7(1):26-34.PMID: 18333158 [PubMed - in process]Related articlesFree article

Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.

Seeff LB, Curto TM, Szabo G, Everson GT, Bonkovsky HL, Dienstag JL, Shiffman ML, Lindsay KL, Lok AS, Di Bisceglie AM, Lee WM, Ghany MG; HALT-C Trial Group.

Hepatology. 2008 Feb;47(2):605-12.PMID: 18157835 [PubMed - indexed for MEDLINE]Related articles

Telbivudine versus lamivudine in patients with chronic hepatitis B.

Lai CL, Gane E, Liaw YF, Hsu CW, Thongsawat S, Wang Y, Chen Y, Heathcote EJ, Rasenack J, Bzowej N, Naoumov NV, Di Bisceglie AM, Zeuzem S, Moon YM, Goodman Z, Chao G, Constance BF, Brown NA; Globe Study Group.

N Engl J Med. 2007 Dec 20;357(25):2576-88.PMID: 18094378 [PubMed - indexed for MEDLINE]Related articlesFree article

Aging liver and hepatitis.

Junaidi O, Di Bisceglie AM.

Clin Geriatr Med. 2007 Nov;23(4):889-903, viii. Review.PMID: 17923344 [PubMed - indexed for MEDLINE]Related articles

Diagnostic and therapeutic approach to hepatocellular carcinoma in the USA.

Di Bisceglie AM, Befeler AS.

Hepatol Res. 2007 Sep;37 Suppl 2:S251-3.PMID: 17877490 [PubMed - in process]Related articles

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C.

Di Bisceglie AM, Ghalib RH, Hamzeh FM, Rustgi VK.

J Viral Hepat. 2007 Oct;14(10):721-9.PMID: 17875007 [PubMed - indexed for MEDLINE]Related articles

Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States.

Peters MG, Di Bisceglie AM, Kowdley KV, Flye NL, Luketic VA, Munoz SJ, Garcia-Tsao G, Boyer TD, Lake JR, Bonacini M, Combes B; PUMPS Group.

Hepatology. 2007 Sep;46(3):769-75.PMID: 17654740 [PubMed - indexed for MEDLINE]Related articles

The AASLD and public policy: coming in out of the cold.

Di Bisceglie AM.

Hepatology. 2007 Jun;45(6):1335-6. Review. No abstract available. PMID: 17538960 [PubMed - indexed for MEDLINE]Related articles

Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy.

Donlin MJ, Cannon NA, Yao E, Li J, Wahed A, Taylor MW, Belle SH, Di Bisceglie AM, Aurora R, Tavis JE; Virahep-C Study Group.

J Virol. 2007 Aug;81(15):8211-24. Epub 2007 May 23.PMID: 17522222 [PubMed - indexed for MEDLINE]Related articlesFree article

Hepatocyte senescence in end-stage chronic liver disease: a study of cyclin-dependent kinase inhibitor p21 in liver biopsies as a marker for progression to hepatocellular carcinoma.

Brunt EM, Walsh SN, Hayashi PH, Labundy J, Di Bisceglie AM.

Liver Int. 2007 Jun;27(5):662-71.PMID: 17498252 [PubMed - indexed for MEDLINE]Related articles

Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Lok AS, Everhart JE, Chung RT, Padmanabhan L, Greenson JK, Shiffman ML, Everson GT, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Ghany MG, Morishima C; HALT-C Trial Group.

Clin Gastroenterol Hepatol. 2007 Feb;5(2):245-54.PMID: 17296533 [PubMed - indexed for MEDLINE]Related articles

Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.

Shiffman ML, Ghany MG, Morgan TR, Wright EC, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Gretch DR.

Gastroenterology. 2007 Jan;132(1):103-12. Epub 2006 Nov 11.PMID: 17241864 [PubMed - indexed for MEDLINE]Related articles

Separation of near full-length hepatitis C virus quasispecies variants from a complex population.

Zhou D, Fan X, Tan D, Xu Y, Tavis JE, Di Bisceglie AM.

J Virol Methods. 2007 May;141(2):220-4. Epub 2007 Jan 8.PMID: 17208310 [PubMed - indexed for MEDLINE]Related articles

Markedly elevated serum CA 19-9 levels in association with a benign biliary stricture due to primary sclerosing cholangitis.

Murray MD, Burton FR, Di Bisceglie AM.

J Clin Gastroenterol. 2007 Jan;41(1):115-7.PMID: 17198074 [PubMed - indexed for MEDLINE]Related articles

Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.

Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR; HALT-C Trial Group.

J Hepatol. 2007 Mar;46(3):420-31. Epub 2006 Nov 27.PMID: 17196293 [PubMed - indexed for MEDLINE]Related articlesFree article

The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis.

Sanyal AJ, Fontana RJ, Di Bisceglie AM, Everhart JE, Doherty MC, Everson GT, Donovan JA, Malet PF, Mehta S, Sheikh MY, Reid AE, Ghany MG, Gretch DR, Halt-C Trial Group.

Gastrointest Endosc. 2006 Dec;64(6):855-64.PMID: 17140886 [PubMed - indexed for MEDLINE]Related articles

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.

Everson GT, Hoefs JC, Seeff LB, Bonkovsky HL, Naishadham D, Shiffman ML, Kahn JA, Lok AS, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Morishima C; HALT-C Trial Group.

Hepatology. 2006 Dec;44(6):1675-84.PMID: 17133499 [PubMed - indexed for MEDLINE]Related articles

Spontaneous retroperitoneal and rectus muscle hemorrhage as a potentially lethal complication of cirrhosis.

Di Bisceglie AM, Richart JM.

Liver Int. 2006 Dec;26(10):1291-3.PMID: 17105596 [PubMed - indexed for MEDLINE]Related articles

Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.

Bonkovsky HL, Naishadham D, Lambrecht RW, Chung RT, Hoefs JC, Nash SR, Rogers TE, Banner BF, Sterling RK, Donovan JA, Fontana RJ, Di Bisceglie AM, Ghany MG, Morishima C; HALT-C Trial Group.

Gastroenterology. 2006 Nov;131(5):1440-51. Epub 2006 Aug 18.PMID: 17101320 [PubMed - indexed for MEDLINE]Related articles

HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.

Morishima C, Morgan TR, Everhart JE, Wright EC, Shiffman ML, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Gretch DR; HALT-C Trial Group.

Hepatology. 2006 Aug;44(2):360-7.PMID: 16871570 [PubMed - indexed for MEDLINE]Related articles

Efficient amplification and cloning of near full-length hepatitis C virus genome from clinical samples.

Fan X, Xu Y, Di Bisceglie AM.

Biochem Biophys Res Commun. 2006 Aug 11;346(4):1163-72. Epub 2006 Jun 14.PMID: 16793008 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics, pharmacodynamics, and hepatitis C viral kinetics during antiviral therapy: the null responder.

Di Bisceglie AM, Fan X, Chambers T, Strinko J.

J Med Virol. 2006 Apr;78(4):446-51.PMID: 16566033 [PubMed - indexed for MEDLINE]Related articles

Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes.

Basu A, Meyer K, Lai KK, Saito K, Di Bisceglie AM, Grosso LE, Ray RB, Ray R.

Virology. 2006 Jun 5;349(2):347-58. Epub 2006 Mar 20.PMID: 16545852 [PubMed - indexed for MEDLINE]Related articles

Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma.

Bialecki ES, Ezenekwe AM, Brunt EM, Collins BT, Ponder TB, Bieneman BK, Di Bisceglie AM.

Clin Gastroenterol Hepatol. 2006 Mar;4(3):361-8.PMID: 16527701 [PubMed - indexed for MEDLINE]Related articles

The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma.

Hayashi PH, Di Bisceglie AM.

Infect Dis Clin North Am. 2006 Mar;20(1):1-25.PMID: 16527646 [PubMed]Related articles

Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.

Morishima C, Polyak SJ, Ray R, Doherty MC, Di Bisceglie AM, Malet PF, Bonkovsky HL, Sullivan DG, Gretch DR, Rothman AL, Koziel MJ, Lindsay KL; Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group.

J Infect Dis. 2006 Apr 1;193(7):931-40. Epub 2006 Feb 22.PMID: 16518754 [PubMed - indexed for MEDLINE]Related articles

Diabetic hepatosclerosis: diabetic microangiopathy of the liver.

Harrison SA, Brunt EM, Goodman ZD, Di Bisceglie AM.

Arch Pathol Lab Med. 2006 Jan;130(1):27-32.PMID: 16390234 [PubMed - indexed for MEDLINE]Related articles

Does bare-stent TIPS increase the risk of hepatocellular carcinoma in patients with cirrhosis?

Di Bisceglie AM.

Nat Clin Pract Gastroenterol Hepatol. 2005 Jun;2(6):256-7. No abstract available. PMID: 16265225 [PubMed]Related articles

Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.

Combes B, Emerson SS, Flye NL, Munoz SJ, Luketic VA, Mayo MJ, McCashland TM, Zetterman RK, Peters MG, Di Bisceglie AM, Benner KG, Kowdley KV, Carithers RL Jr, Rosoff L Jr, Garcia-Tsao G, Boyer JL, Boyer TD, Martinez EJ, Bass NM, Lake JR, Barnes DS, Bonacini M, Lindsay KL, Mills AS, Markin RS, Rubin R, West AB, Wheeler DE, Contos MJ, Hofmann AF.

Hepatology. 2005 Nov;42(5):1184-93.PMID: 16250039 [PubMed - indexed for MEDLINE]Related articles

Pretransplant treatments for hepatocellular carcinoma: do they improve outcomes?

Di Bisceglie AM.

Liver Transpl. 2005 Nov;11(11 Suppl 2):S10-3. Review.PMID: 16237728 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, Wright EC, Everson GT, Lindsay KL, Lok AS, Lee WM, Morgan TR, Ghany MG, Gretch DR; HALT-C Trial Group.

J Hepatol. 2005 Sep;43(3):434-41.PMID: 16136646 [PubMed - indexed for MEDLINE]Related articles